Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bioactive Foam Scaffold Helps Replace Lost Bone

By HospiMedica International staff writers
Posted on 19 Apr 2017
Novel malleable bioactive foam can be used to treat craniomaxillofacial osseous gaps in the skull resulting from injury, surgery, or birth defects.

Under development by researchers at the Rensselaer Polytechnic Institute and Texas A&M University, the bioactive foam is based on a shape memory polymer (SMP) made of crosslinked poly(ε-caprolactone) (PCL) diacrylate coated in a bioactive polydopamine. More...
When exposed to warm saline, the foam material becomes pliable, allowing it to be easily shaped to fit irregular defects in the skull.

Subsequent cooling causes the scaffold to lock in its temporary shape within the defect. Once in place, the SMP exhibits an interconnected pore morphology and bioactivity that enhance tissue regeneration, thanks to the polydopamine-coating, which promotes superior bioactivity, osteoblast adhesion and proliferation, osteogenic gene expression, and extracellular matrix (ECM) deposition. The formation of hydroxyapatite naturally regenerates bone that eventually replaces the foam with de-novo bone.

“The approach has a number of advantages, particularly when contrasted with other options under research, such as 3D printing methods,” said professor of biomedical engineering Mariah Hahn, PhD, of RPI. “A moldable bone-promoting scaffold could have broad use if it's successful. It takes advantages of the body's own healing ability, and it's a low-cost, ‘off the shelf’ solution that would not need to be pre-tailored to the individual defect.”

“Rigid bone graft cannot be readily manipulated to fit within the irregularly shaped bone defect. Due to the lack of fit and good contact with neighboring bone tissue, defect healing is compromised. This is like trying to fill in a missing puzzle piece with the wrong piece,” said associate professor of biomedical engineering Melissa Grunlan, PhD, of TAMU. “These bone defects can cause tremendous functional problems and aesthetic issues for individuals, so it was recognized that a better treatment would make a big impact.”

SMPs include foams, scaffolds, meshes, and other polymeric substrates that have the ability to return from a deformed (temporary) state to their original (permanent) shape induced by an external stimulus such as temperature change, an electric or magnetic field, light, or a solution. Similar to polymers in general, SMPs also cover a wide property-range from stable to biodegradable, from soft to hard, and from elastic to rigid, depending on the structural units that constitute the SMP.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.